Clinical Trials for Platelet Transfusion Refractoriness

Find clinical trials for platelet transfusion refractoriness. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness

NCT ID: NCT06792019

This clinical trial is testing a new treatment, called CM313(SC) injection, for people who have difficulty receiving platelet transfusions due to a condition known as platelet transfusion refractor...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Tianjin, Tianjin, China

Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness

NCT ID: NCT06254560

This clinical trial is studying the use of rituximab, a medication, for patients with severe aplastic anemia (SAA) who have trouble receiving effective platelet transfusions, a condition known as p...

Recruiting

Phase: PHASE2 Type: interventional Locations: Tianjin, Tianjin, China

Platelet Transfusion Refractoriness

NCT ID: NCT05399693

This clinical trial is studying a condition called Platelet Transfusion Refractoriness, which can happen after patients receive many platelet transfusions. This condition makes it difficult for pat...

Recruiting

Type: observational Locations: Strasbourg, , France

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions